Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,0567,07-1,18
Msft0,37
Nokia3,40353,4105-0,04
IBM1,05
Mercedes-Benz Group AG73,9173,93-0,04
PFE-0,19
25.04.2024 1:38:56
Indexy online
AD Index online
select
AD Index online
 

  • 24.04.2024
Pharmagest Interac. (Paris)
Závěr k 24.4.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
59,40 -0,67 -0,40 257 806
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 25.04.2024
Popis společnosti
Obecné informace
Název společnostiEquasens SA
TickerEQS
Kmenové akcie:Ordinary Shares
RICEQSE.PA
ISINFR0012882389
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2022 1 221
Akcie v oběhu k 30.06.2023 15 033 281
MěnaEUR
Kontaktní informace
Ulice5 Allee de Saint-Cloud
MěstoVILLERS LES NANCY
PSČ54600
ZeměFrance
Kontatní osoba 
Funkce kontaktní osoby 
Telefon33 383 159 595
Fax33383159805

Business Summary: Equasens SA is formerly known as Pharmagest Interactive SA is a France-based company. The Company is engaged in the development and integration of management software packages for drugstores. It offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The Company operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.
Financial Summary: BRIEF: For the six months ended 30 June 2023, Equasens SA revenues increased 9% to EUR112.6M. Net income applicable to common stockholders increased 11% to EUR22M. Revenues reflect Pharmacy segment increase of 10% to EUR83.7M, Other segment increase of 11% to EUR14M. Net income benefited from Pharmacy segment income increase of 8% to EUR18.4M, Other segment income increase of 10% to EUR4.5M.
Odvětvová klasifikace
TRBC2009Software
TRBC2012IT Services & Consulting (NEC)
RBSS2004Software
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSSoftware Publishers
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Software Publishers
NAICS2007Electromedical Apparatus Mfg
NAICS1997Software Publishers
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICPrepackaged Software
SICElectromedical Equipment



  • Poslední aktualizace: 25.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardThierry Chapusot6401.01.2010
Group Administrative and Finance Director, Member of the Executive CommitteeFrederique Schmidt-01.01.202301.01.2023
Chief Operating Officer, Member of the Management Board, DirectorGregoire de Rotalier5308.07.2020
General Manager, Member of the Management Board, DirectorDenis Supplisson5422.04.2022